baclofen has been researched along with neuropeptide y in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 11 (47.83) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colmers, WF; Klapstein, GJ | 1 |
| Couture, R; De Champlain, J; Hasséssian, H; Prat, A | 1 |
| Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ | 1 |
| Colmers, WF; Pittman, QJ | 1 |
| Douglas, WW; Shibuya, I | 1 |
| de Koning, HP; Jenks, BG; Leenders, HJ; Ponten, SP; Roubos, EW | 1 |
| Albus, K; Baumfalk, U; Hicks, TP; Kaneko, T | 1 |
| Cruijsen, PM; Dotman, CH; Jenks, BG; Roubos, EW | 1 |
| Jenks, BG; Lieste, JR; Roubos, EW; Scheenen, WJ; Willems, PH | 1 |
| Colmers, WF; Qian, J; Saggau, P | 1 |
| Bartfai, T; Brodin, L; Grillner, S; Langel, U; Larhammar, D; Parker, D; Shupliakov, O; Söderberg, C; Zotova, E | 1 |
| Biggs, KR; Prosser, RA | 1 |
| Grillner, S; Parker, D; Svensson, E; Ullström, M | 1 |
| Altobelli, D; Fuxe, K; Martire, M; Maurizi, S; Preziosi, P | 1 |
| Cai, X; Friedman, JM; Jackson, AC; Liu, H; Roseberry, AG | 1 |
| Gallate, JE; McGregor, IS | 1 |
| Funahashi, H; Muroya, S; Shioda, S; Uramura, K; Yada, T | 1 |
| Jenks, BG; Roubos, EW; Scheenen, WJ; Zhang, H | 1 |
| Egli, M; Heilig, M | 1 |
| Noebels, JL; Qian, J | 1 |
| Arima, H; Banno, R; Goto, M; Hayashi, M; Nagasaki, H; Oiso, Y; Ozaki, N; Sato, I; Shimizu, H; Watanabe, M | 1 |
| Chen, SH; Li, SF; Lin, CT; Lue, JH; Tsai, YJ; Wang, HY | 1 |
| Bosch, MA; Kelly, MJ; Rønnekleiv, OK; Smith, AW; Wagner, EJ | 1 |
1 review(s) available for baclofen and neuropeptide y
| Article | Year |
|---|---|
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Baclofen; Corticotropin-Releasing Hormone; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Neuropeptide Y; Nociceptin; Ondansetron; Opioid Peptides; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Taurine; Topiramate | 2006 |
22 other study(ies) available for baclofen and neuropeptide y
| Article | Year |
|---|---|
4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro.
Topics: 2-Chloroadenosine; 4-Aminopyridine; Animals; Baclofen; Calcium; Hippocampus; In Vitro Techniques; Male; Neuropeptide Y; Rats; Rats, Inbred Strains; Receptors, Neuropeptide Y; Receptors, Neurotransmitter; Receptors, Purinergic; Synapses; Synaptic Transmission | 1992 |
Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord.
Topics: Animals; Baclofen; Bicuculline; Blood Pressure; Capsaicin; Cardiovascular Physiological Phenomena; Cardiovascular System; Catecholamines; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Glycine; Heart Rate; Injections, Spinal; Male; Muscimol; Neurons; Neuropeptide Y; Rats; Rats, Inbred Strains; Receptors, GABA-A; Spinal Cord; Substance P; Sympathetic Nervous System | 1991 |
Systemic approaches to modifying quinolinic acid striatal lesions in rats.
Topics: 2-Amino-5-phosphonovalerate; Allopurinol; Amino Acids; Animals; Antioxidants; Baclofen; Corpus Striatum; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; Huntington Disease; Ketamine; Male; Neuropeptide Y; Nimodipine; Peptides; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Substance P; Taurine; Valine | 1988 |
Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertussis toxin treatment.
Topics: Animals; Baclofen; GTP-Binding Proteins; Hippocampus; Male; Neural Inhibition; Neuropeptide Y; Pertussis Toxin; Rats; Rats, Inbred Strains; Virulence Factors, Bordetella | 1989 |
Spontaneous cytosolic calcium pulsing detected in Xenopus melanotrophs: modulation by secreto-inhibitory and stimulant ligands.
Topics: Animals; Baclofen; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytosol; Dopamine; Female; gamma-Aminobutyric Acid; Male; Melanocyte-Stimulating Hormones; Muscimol; Neuropeptide Y; Nickel; Periodicity; Pertussis Toxin; Pituitary Gland; Receptors, GABA-A; Virulence Factors, Bordetella; Xenopus laevis | 1993 |
Differential effects of coexisting dopamine, GABA and NPY on alpha-MSH secretion from melanotrope cells of Xenopus laevis.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; alpha-MSH; Animals; Baclofen; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; In Vitro Techniques; Isonicotinic Acids; Kinetics; Neuropeptide Y; Perfusion; Pituitary Gland; Radioimmunoassay; Xenopus laevis | 1993 |
Examination of the effects of cholecystokinin 26-33 and neuropeptide Y on responses of visual cortical neurons of the cat.
Topics: Animals; Baclofen; Cats; Cholecystokinin; Evoked Potentials, Visual; gamma-Aminobutyric Acid; Iontophoresis; Neural Conduction; Neurons; Neuropeptide Y; Photic Stimulation; Proglumide; Sincalide; Tachyphylaxis; Visual Cortex | 1993 |
Differential action of secreto-inhibitors on proopiomelanocortin biosynthesis in the intermediate pituitary of Xenopus laevis.
Topics: alpha-MSH; Analysis of Variance; Animals; Apomorphine; Baclofen; GABA Agonists; GABA-A Receptor Agonists; GABA-B Receptor Agonists; In Vitro Techniques; Isonicotinic Acids; Kinetics; Neuropeptide Y; Pituitary Gland; Pro-Opiomelanocortin; Receptors, Dopamine D2; Xenopus laevis | 1996 |
Calcium oscillations in melanotrope cells of Xenopus laevis are differentially regulated by cAMP-dependent and cAMP-independent mechanisms.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amphibian Proteins; Animals; Baclofen; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Drug Interactions; Enzyme Inhibitors; Female; Fluorescent Dyes; Fura-2; GABA Agonists; Isoquinolines; Male; Microscopy, Video; Neuropeptide Y; Peptide Hormones; Peptides; Periodicity; Pituitary Gland; Sulfonamides; Vasodilator Agents; Xenopus laevis | 1996 |
Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry.
Topics: Adenosine; Animals; Baclofen; Calcium; Calcium Channels; Calcium Channels, N-Type; Electric Stimulation; GTP-Binding Proteins; Hippocampus; Ion Channel Gating; Ion Transport; Male; Models, Neurological; Nerve Tissue Proteins; Neuropeptide Y; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptide Fragments; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, Neuropeptide Y; Receptors, Purinergic P1; Signal Transduction; Spider Venoms; Synaptic Transmission | 1997 |
Co-localized neuropeptide Y and GABA have complementary presynaptic effects on sensory synaptic transmission.
Topics: Animals; Baclofen; Female; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Ganglia, Spinal; Glutamine; Immunohistochemistry; Intracellular Fluid; Lampreys; Male; Neurons, Afferent; Neuropeptide Y; Presynaptic Terminals; Receptors, Neuropeptide Y; Spinal Cord; Synaptic Transmission | 1998 |
Neuropeptide Y blocks GABAB-induced phase-shifts of the suprachiasmatic circadian clock in vitro.
Topics: Animals; Baclofen; Circadian Rhythm; Dose-Response Relationship, Drug; GABA Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Suprachiasmatic Nucleus | 1999 |
Neuropeptide-mediated facilitation and inhibition of sensory inputs and spinal cord reflexes in the lamprey.
Topics: Action Potentials; Analgesics; Animals; Baclofen; Behavior, Animal; Bombesin; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; GABA Agonists; Lampreys; Male; N-Methylaspartate; Neurons, Afferent; Neuropeptide Y; Reflex; Spinal Cord; Substance P; Swimming; Synapses | 1999 |
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Topics: Animals; Aspartic Acid; Baclofen; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Ion Channel Gating; Male; Nerve Endings; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; Peptide Fragments; Potassium; Protein Isoforms; Rats; Rats, Wistar; Spinal Cord; Stereoisomerism; Synaptosomes | 2000 |
Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice.
Topics: Action Potentials; Animals; Arcuate Nucleus of Hypothalamus; Baclofen; Enkephalin, Methionine; In Vitro Techniques; Mice; Mice, Obese; Mice, Transgenic; Neural Inhibition; Neurons; Neuropeptide Y; Pro-Opiomelanocortin | 2004 |
Rats on the grog: novel pharmacotherapies for alcohol craving.
Topics: Alcoholism; Animals; Baclofen; Beer; Behavior, Addictive; Cannabinoid Receptor Antagonists; Corticotropin-Releasing Hormone; Humans; Models, Animal; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Piperidines; Pyrazoles; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, GABA-B; Research Design; Rimonabant | 2004 |
Gamma aminobutyric acid regulates glucosensitive neuropeptide Y neurons in arcuate nucleus via A/B receptors.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Baclofen; Bicuculline; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glucose; Immunohistochemistry; Male; Microscopy, Immunoelectron; Muscimol; Neurons; Neuropeptide Y; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, GABA; Time Factors | 2005 |
Receptors for neuropeptide Y, gamma-aminobutyric acid and dopamine differentially regulate Ca2+ currents in Xenopus melanotrope cells via the G(i) protein beta/gamma-subunit.
Topics: Animals; Apomorphine; Baclofen; Calcium; Calcium Channels; Cells, Cultured; Dopamine Agonists; Electric Conductivity; GABA Agonists; GABA-B Receptor Agonists; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Melanocyte-Stimulating Hormones; Neuropeptide Y; Patch-Clamp Techniques; Pituitary Gland; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Receptors, GABA-B; Receptors, Neuropeptide Y; Xenopus laevis | 2006 |
Exocytosis of vesicular zinc reveals persistent depression of neurotransmitter release during metabotropic glutamate receptor long-term depression at the hippocampal CA3-CA1 synapse.
Topics: Action Potentials; Adenosine; Animals; Baclofen; Carrier Proteins; Cation Transport Proteins; Crosses, Genetic; Excitatory Postsynaptic Potentials; Exocytosis; Hippocampus; Long-Term Synaptic Depression; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Neurotransmitter Agents; Receptors, Metabotropic Glutamate; Synapses; Zinc | 2006 |
Peripherally administered baclofen reduced food intake and body weight in db/db as well as diet-induced obese mice.
Topics: Adipokines; Adipose Tissue, White; Administration, Oral; Animals; Anti-Obesity Agents; Arcuate Nucleus of Hypothalamus; Baclofen; Blood Glucose; Diet; Eating; GABA Agonists; GABA-B Receptor Agonists; Male; Mice; Mice, Obese; Neuropeptide Y; Obesity; Pro-Opiomelanocortin; RNA, Messenger; Weight Loss | 2007 |
Changes in GABA and GABA(B) receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection.
Topics: Animals; Baclofen; Electric Stimulation; GABA Antagonists; Gait; gamma-Aminobutyric Acid; Ganglia, Spinal; Male; Median Nerve; Median Neuropathy; Medulla Oblongata; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, GABA-B | 2012 |
The membrane estrogen receptor ligand STX rapidly enhances GABAergic signaling in NPY/AgRP neurons: role in mediating the anorexigenic effects of 17β-estradiol.
Topics: Acrylamides; Animals; Baclofen; Estradiol; Estrogen Receptor alpha; Female; GABA-B Receptor Agonists; Guinea Pigs; Hypothalamus; Male; Mice; Mice, Transgenic; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Receptors, GABA-B; Signal Transduction | 2013 |